Matthew Kennedy 人物
相关论文查看全部 (3)
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
2020Nature Medicine引用 441
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
2016Science Translational Medicine引用 415
Function, therapeutic potential and cell biology of <scp>BACE</scp> proteases: current status and future prospects
2014Journal of Neurochemistry引用 311
相关公司查看全部 (2)
相关事件
暂无数据
相关专利
暂无数据
相关文章
暂无数据